(Trimethoxyphenylamino) pyrimidinyl formulations

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8771648
APP PUB NO 20130058876A1
SERIAL NO

13559805

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

There are provided pharmaceutical compositions comprising greater than 15% w/w of a compound of Formula (I) as defined herein and/or hydrate thereof and an amount of one or more effervescent agents that is sufficient to provide satisfactory in vitro dissolution; and further comprising one or more pharmaceutically acceptable ingredients; and to processes for obtaining them.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RIGEL PHARMACEUTICALS INC611 GATEWAY BOULEVARD SUITE 900 SOUTH SAN FRANCISCO CA 94080

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alhusban, Farhan Abdul Karim Macclesfield, GB 2 1
Gabbott, Ian Paul Macclesfield, GB 2 1
Gururajan, Bindhumadhavan Mölndal, SE 6 4
Sievwright, Dawn Macclesfield, GB 2 1
Simpson, David Bradley Brook Macclesfield, GB 7 128

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 8, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00